AI-generated summary
The authors reviewed in vitro and in vivo studies of red and near-infrared photobiomodulation on endothelial dysfunction, selecting 50 articles from more than 12,000 found. They report that photobiomodulation can modulate inflammation, angiogenesis and vasodilatation, and describe specific settings linked to restenosis prevention and angiogenesis stimulation. The authors state that more extensive randomised controlled trials are necessary.
- Studies included
- 50
- Who or what was studied
- Endothelial cells and endothelial dysfunction, studied in vitro and in vivo
- Wavelengths
- 645, 808 nm
- Limits stated in the abstract
- The authors state that more extensive randomised controlled trials are necessary.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Under physiological conditions, endothelial cells are the main regulator of arterial tone homeostasis and vascular growth, sensing and transducing signals between tissue and blood. Disease risk factors can lead to their unbalanced homeostasis, known as endothelial dysfunction. Red and near-infrared light can interact with animal cells and modulate their metabolism upon interaction with mitochondria's cytochromes, which leads to increased oxygen consumption, ATP production and ROS, as well as to regulate NO release and intracellular Ca2+ concentration. This medical subject is known as photobiomodulation (PBM). We present a review of the literature on the in vitro and in vivo effects of PBM on endothelial dysfunction.
Methods
A search strategy was developed consistent with the PRISMA statement. The PubMed, Scopus, Cochrane, and Scholar electronic databases were consulted to search for in vitro and in vivo studies.
Results
Fifty out of >12,000 articles were selected.
Conclusions
The PBM can modulate endothelial dysfunction, improving inflammation, angiogenesis, and vasodilatation. Among the studies, 808 nm and 18 J (0.2 W, 2.05 cm2) intracoronary irradiation can prevent restenosis as well as 645 nm and 20 J (0.25 W, 2 cm2) can stimulate angiogenesis. PBM can also support hypertension cure. However, more extensive randomised controlled trials are necessary.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm, 645 nm
- Power
- 0.2 W, 0.25 W
- Total energy
- 18 J, 20 J
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Near-infrared, Angiogenesis, Reactive oxygen species, Adenosine triphosphate, Inflammation, Mitochondria. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.